The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, ...

GenEditBio Limited ("GenEditBio"), a clinical-stage biotechnology startup focusing on genome-editing therapeutic solutions, today announced that the U.S.

The clearance allows human trials for its one-time treatment targeting a genetic eye disease that causes vision loss.

As of Wednesday, January 07, Design Therapeutics, Inc.’s DSGN share price has surged by 8.50%, which has investors questioning if this is right time to sell.

As businesses prepare for critical 1099 filing deadlines, Halfpricesoft.com boasts ez1099 , as the reliable and user-friendly solution. It's design will simplify 1099 form preparation and ensure ...

BC.GAME Esports today announced a roster upgrade for its Counter-Strike 2 (CS2) programme, confirming the signings of three players from Portuguese side SAW: Christopher "MUTiRiS" Fernandes, Adones ...

A Scots pensioner who "spent half his life in the dark" will be able to see Christmas properly for the first time in years after receiving a life-changing cornea transplant. David Watkins, 72, from ...

The firm plans to enroll US patients into the trial of GEB-101 in the second quarter, having launched an investigator-initiated trial in China.

Searching the IRIS Registry for the years 2016 to 2022, they found data entered for 67,855,466 patients. Applying the ICD ...

Patients who experience adverse ocular effects with bisphosphonates have a notably higher risk for osteonecrosis than those who do not experience such events, a large cohort study shows.